Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bright Minds Biosciences Inc (DRUG)

Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 252,034
  • Shares Outstanding, K 7,044
  • Annual Sales, $ 0 K
  • Annual Income, $ -2,060 K
  • EBIT $ -2 M
  • EBITDA $ -2 M
  • 60-Month Beta -6.45
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.89

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.38
  • Number of Estimates 2
  • High Estimate -0.20
  • Low Estimate -0.56
  • Prior Year -0.10
  • Growth Rate Est. (year over year) -280.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.05 +15.23%
on 03/04/25
42.11 -15.03%
on 02/18/25
-6.02 (-14.40%)
since 02/14/25
3-Month
28.21 +26.83%
on 01/28/25
47.50 -24.67%
on 02/13/25
-5.22 (-12.73%)
since 12/13/24
52-Week
0.93 +3,747.31%
on 04/30/24
79.02 -54.72%
on 10/18/24
+34.48 (+2,652.31%)
since 03/14/24

Most Recent Stories

More News
Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Leaders in Epilepsy Research

DRUG : 35.78 (-0.78%)
DRUG.CN : 51.7100 (unch)
Bright Minds Biosciences to Participate at Three Healthcare Conferences in March

DRUG : 35.78 (-0.78%)
DRUG.CN : 51.7100 (unch)
Biotechs on the Brink: 2 Stocks With Huge Potential

BriaCell Therapeutics and Recursion Pharmaceuticals are two biotech firms that may be poised for success in 2025; risk-tolerant investors might keep an eye out.

DRUG : 35.78 (-0.78%)
BCTX : 3.84 (+11.30%)
RXRX : 6.35 (+6.90%)
Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer

DRUG : 35.78 (-0.78%)
DRUG.CN : 51.7100 (unch)
Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting

DRUG : 35.78 (-0.78%)
DRUG.CN : 51.7100 (unch)
Meet the Biotech Stock That Has Generated Nvidia-Like Returns in Less Than a Month

The reason for the stock's rapid ascent is a mystery.

DRUG : 35.78 (-0.78%)
NVDA : 121.67 (+5.27%)
Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement

DRUG : 35.78 (-0.78%)
DRUG.CN : 51.7100 (unch)
Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data

DRUG : 35.78 (-0.78%)
DRUG.CN : 51.7100 (unch)
MarketBeat Week in Review – 10/14 - 10/18

Stocks struggled for direction, but the trend before tech earnings is still bullish. Nevertheless, investors should expect volatility ahead of the election.

WHR : 90.98 (+2.71%)
DRUG : 35.78 (-0.78%)
GOOGL : 165.49 (+1.68%)
NVDA : 121.67 (+5.27%)
CRWD : 353.73 (+6.38%)
CVX : 157.02 (+2.22%)
BAC : 40.89 (+3.08%)
OXY : 46.53 (+2.38%)
TSLA : 249.98 (+3.86%)
ABT : 126.71 (-2.45%)
XOM : 111.90 (+2.97%)
HOOD : 39.24 (+8.94%)
Bright Minds Biosciences Announces US$35 Million Non-Brokered Private Placement

DRUG : 35.78 (-0.78%)
DRUG.CN : 51.7100 (unch)

Business Summary

Bright Minds Biosciences is a biotechnology company. It focused on developing novel drugs for targeted treatment of neuropsychiatric disorders, epilepsy and pain. Bright Minds Biosciences is based in VANCOUVER, British Columbia.

See More

Key Turning Points

3rd Resistance Point 37.65
2nd Resistance Point 37.21
1st Resistance Point 36.50
Last Price 35.78
1st Support Level 35.34
2nd Support Level 34.90
3rd Support Level 34.19

See More

52-Week High 79.02
Fibonacci 61.8% 49.19
Fibonacci 50% 39.97
Last Price 35.78
Fibonacci 38.2% 30.76
52-Week Low 0.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar